137 related articles for article (PubMed ID: 29309919)
1. Expanding LogP: Present possibilities.
Vraka C; Mijailovic S; Fröhlich V; Zeilinger M; Klebermass EM; Wadsak W; Wagner KH; Hacker M; Mitterhauser M
Nucl Med Biol; 2018 Mar; 58():20-32. PubMed ID: 29309919
[TBL] [Abstract][Full Text] [Related]
2. LogP, a yesterday's value?
Vraka C; Nics L; Wagner KH; Hacker M; Wadsak W; Mitterhauser M
Nucl Med Biol; 2017 Jul; 50():1-10. PubMed ID: 28364662
[TBL] [Abstract][Full Text] [Related]
3. Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier.
Reichel A; Begley DJ
Pharm Res; 1998 Aug; 15(8):1270-4. PubMed ID: 9706060
[TBL] [Abstract][Full Text] [Related]
4. Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography.
Yoon CH; Kim SJ; Shin BS; Lee KC; Yoo SD
J Biomol Screen; 2006 Feb; 11(1):13-20. PubMed ID: 16314407
[TBL] [Abstract][Full Text] [Related]
5. Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs.
Grumetto L; Russo G; Barbato F
Mol Pharm; 2016 Aug; 13(8):2808-16. PubMed ID: 27377191
[TBL] [Abstract][Full Text] [Related]
6. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
Grumetto L; Russo G; Barbato F
Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
[TBL] [Abstract][Full Text] [Related]
7. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
8. Radiotracer properties determined by high performance liquid chromatography: a potential tool for brain radiotracer discovery.
Tavares AA; Lewsey J; Dewar D; Pimlott SL
Nucl Med Biol; 2012 Jan; 39(1):127-35. PubMed ID: 21958855
[TBL] [Abstract][Full Text] [Related]
9. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols.
Stępnik KE; Malinowska I
J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703
[TBL] [Abstract][Full Text] [Related]
10. Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.
Grumetto L; Carpentiero C; Di Vaio P; Frecentese F; Barbato F
J Pharm Biomed Anal; 2013 Mar; 75():165-72. PubMed ID: 23261809
[TBL] [Abstract][Full Text] [Related]
11. pH-dependent surface electrostatic effects in retention on immobilized artificial membrane chromatography: Determination of the intrinsic phospholipid-water sorption coefficients of diverse analytes.
Yang YX; Zhang Q; Li QQ; Xia ZN; Chen H; Zhou K; Yang FQ
J Chromatogr A; 2018 Oct; 1570():172-182. PubMed ID: 30086834
[TBL] [Abstract][Full Text] [Related]
12. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
Jiang L; Chen J; He Y; Zhang Y; Li G
J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
[TBL] [Abstract][Full Text] [Related]
13. Application of PAMPA-models to predict BBB permeability including efflux ratio, plasma protein binding and physicochemical parameters.
Mensch J; Jaroskova L; Sanderson W; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Int J Pharm; 2010 Aug; 395(1-2):182-97. PubMed ID: 20635475
[TBL] [Abstract][Full Text] [Related]
14. The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeability.
Lingineni K; Belekar V; Tangadpalliwar SR; Garg P
Mol Divers; 2017 May; 21(2):355-365. PubMed ID: 28050687
[TBL] [Abstract][Full Text] [Related]
15. Validation of in vitro cell-based human blood-brain barrier model using clinical positron emission tomography radioligands to predict in vivo human brain penetration.
Mabondzo A; Bottlaender M; Guyot AC; Tsaouin K; Deverre JR; Balimane PV
Mol Pharm; 2010 Oct; 7(5):1805-15. PubMed ID: 20795735
[TBL] [Abstract][Full Text] [Related]
16. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
17. Progress in brain penetration evaluation in drug discovery and development.
Liu X; Chen C; Smith BJ
J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
[TBL] [Abstract][Full Text] [Related]
18. Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood-Brain Barrier in Glioblastoma Patients Using an IVIVE-PBPK Modeling Approach.
Li J; Wu J; Bao X; Honea N; Xie Y; Kim S; Sparreboom A; Sanai N
Clin Cancer Res; 2017 Dec; 23(24):7454-7466. PubMed ID: 28928160
[No Abstract] [Full Text] [Related]
19. Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data.
Grumetto L; Carpentiero C; Barbato F
Eur J Pharm Sci; 2012 Apr; 45(5):685-92. PubMed ID: 22306648
[TBL] [Abstract][Full Text] [Related]
20. Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases.
Janicka M; Sztanke M; Sztanke K
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
